New drug target discovered for aggressive prostate cancer
Drug Discovery World
SEPTEMBER 18, 2024
Scientists have discovered that a protein linked to prostate cancer is associated with more aggressive disease and could be a new target for treatment. The team at The Institute of Cancer Research, London, UK, have shown that the BCL2 protein was abundant in a subtype of advanced prostate cancer which has stopped responding to hormone therapy. The researchers estimate that around 10% of people with prostate cancer have high levels of this protein.
Let's personalize your content